SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) JANUARY 29, 2002
------------------------------
MERCK & CO., INC.
-------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in Its Charter)
NEW JERSEY
-------------------------------------------------------------------------------
(State or Other Jurisdiction of Incorporation)
1-3305 22-1109110
----------------------------------- ------------------------------------
(Commission File Number) (I.R.S. Employer Identification No.)
ONE MERCK DRIVE, PO BOX 100, WHITEHOUSE STATION, NJ 08889-0100
-------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code (908) 423-1000
----------------------------
ITEM 5. OTHER EVENTS
---------------------
Incorporated by reference is a press release issued by the Registrant on January
29, 2002, attached as Exhibit 99, concerning the Registrant's announcement that
it plans to establish Merck-Medco, its pharmacy benefits management (PBM)
subsidiary, as a separate, publicly traded company.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(c) EXHIBITS
Exhibit 99 Press release issued Filed with
January 29, 2002 this document
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
MERCK & CO., Inc.
Date: January 30, 2002 By: /s/ Debra A. Bollwage
---------------------------
DEBRA A. BOLLWAGE
Assistant Secretary
EXHIBIT INDEX
-------------
Exhibit
Number Description
------- -----------
99 Press release issued January 29, 2002